TILT Holdings Inc.

TILT

CA88688R1047

Pharmaceuticals

End-of-day quote NEO Exchange Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
0.035 ^CAD	-12.50%		-22.22%	+16.67%

Mar. 14	Transcript : TILT Holdings Inc., Q4 2023 Earnings Call, Mar 14, 2024
Mar. 14	TILT Holdings Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

TILT Holdings Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023

March 14, 2024 at 04:05 pm EDT

TILT Holdings Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 37.54 million compared to USD 44.29 million a year ago. Net loss was USD 21.95 million compared to USD 73.08 million a year ago.
For the full year, sales was USD 165.96 million compared to USD 174.19 million a year ago. Net loss was USD 62.38 million compared to USD 107.46 million a year ago.

Latest news about TILT Holdings Inc.

Transcript : TILT Holdings Inc., Q4 2023 Earnings Call, Mar 14, 2024	Mar. 14
TILT Holdings Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 14	CI
Tilt Holdings Announces New Brand Partnership with LEVEL to Bring Cannabis Tablets to Pennsylvania	Mar. 13	CI
Transcript : TILT Holdings Inc., Q3 2023 Earnings Call, Nov 13, 2023	Nov. 13
TILT Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
TILT Holdings Inc. Announces Board Changes	23-09-26	CI
TILT Holdings Inc. Appoints Tim Conder as Permanent CEO	23-09-26	CI
Transcript : TILT Holdings Inc., Q2 2023 Earnings Call, Aug 14, 2023	23-08-14
TILT Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
TILT Holdings Inc. Announces Board Changes	23-06-08	CI
TILT Holdings Inc. Announces Chief Financial Officer Changes	23-05-22	CI
TILT Holdings Inc. Announces Closing of an Offering of Up to USD 4.5 Million in Aggregate Principal Amount of Senior Secured Promissory Notes	23-05-16	CI
TILT Holdings Inc. announced that it has received $4 million in funding	23-05-15	CI
TILT Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Transcript : TILT Holdings Inc., Q1 2023 Earnings Call, May 15, 2023	23-05-15
TILT Holdings Inc. Announces Executive Changes	23-04-24	CI
TILT Holdings Inc. Announces Executive Changes	23-04-24	CI
TILT Holdings Inc. Announces Adam R. Draizin to its Committes	23-03-21	CI
TILT Holdings Inc. Assigns George Odden to the Audit Committee and Compensation Committee	23-03-21	CI
Transcript : TILT Holdings Inc., Q4 2022 Earnings Call, Mar 16, 2023	23-03-16
TILT Holdings Inc. Appoints George Odden as Board of Directors	23-03-14	CI
TILT Holdings Inc. announced that it has received $14.777458 million in funding	23-02-28	CI
TILT Holdings Inc. Enters into Licensing Agreement to Bring Thredz	23-02-28	CI
Doobie Announces Direct-To-Consumer Recreational Cannabis Delivery Partnership with Tilt Holdings	23-02-16	CI
TILT Holdings Completes the Refinancing of Its Legacy Debt, Successfully Reduces Outstanding Debt by 47% Year over Year	23-02-16	CI

Chart TILT Holdings Inc.

Duration

Period

More charts

Company Profile

TILT Holdings Inc. (TILT) is a Canada-based company. The Company is a business solutions provider to the global cannabis industry offering a diverse range of value-added products and services to industry participants. The Company operates through four segments: Cannabis, Accessories, Corporate, and Other. The Company offers technology, equipment, cultivation, and production services through its portfolio companies. It is organized in three business focuses: Consumer Devices & Packaged Goods, Cultivation and Production, and Retail. The Company is organized in various business units: inhalation technologies, cultivation, manufacturing, processing, brand development and retail. TILT services brands and cannabis retailers across 39 states in the Unites States as well as Canada, Israel, South America, and the European Union. The Company's subsidiaries include Commonwealth Alternative Care, Inc., White Haven RE, LLC, and Jupiter Research, LLC.

Sector

Pharmaceuticals

Calendar

2024-05-14 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for TILT Holdings Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.035

Average target price

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
TILT HOLDINGS INC.	+16.67%	9.91M
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B

Alternative Medicine